Mesa Laboratories Inc (MLAB) stock forecast · P/E 81, rev $249.1M
Mesa Laboratories Inc (MLAB) is a scientific & technical instruments company listed on US.
This MLAB forecast page states what the cached financials imply — not a price target and not a guarantee. Mesa Laboratories Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported MLAB revenue for 2026-03-31 was $249.1M. Net income was $6.7M. Revenue was up 3.4% from 2025-03-31 to 2026-03-31. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
The near-term path: Revenue was up 3.4% from 2025-03-31 to 2026-03-31. A forecast that ignores that change is just a story.
MLAB currently screens at market cap $538.3M and trailing P/E 80.5. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next MLAB 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the MLAB stock page.
Not investment advice.